Abbott said a recent study shows its MitraClip system used in transcatheter mitral valve repair surgery helps people fight a heart condition in which blood flows back into the left atrium because the mitral valve does not close tightly, a condition known as degenerative mitral regurgitation.
One-year results of the study show promise for the MitraClip (mitral clip) system to help people who are battling the condition, also known as a leaky heart valve, Abbott said in a release.
The study looked at the Transcatheter Valve Therapy registry information of almost 3,000 people battling degenerative mitral regurgitation who were likely to need surgery. After the MitraClip was implanted into those people, 92.8 percent showed improvement, the release said.
The study also noted 80 percent of the patients studied did not have to return to the hospital for heart failure during the year after the MitraClip was put in, the release said. Also, 85.9 percent of those who had the MitraClip implanted went home after being at the hospital for two days.
